資料搜尋諮詢服務
找不到您所需要的資料嗎?
我們能協助您找到最符合您研究需求的資訊
請撥打 +886-2-2799-3110
或透過電子郵件與我們聯絡 mi@hintoninfo.com
IHS_EWBIEEE xploreSTRATEGY ANALYTICSIHS_EWB_GF

頁面路徑選單

Infection Control Market Analysis By Type (Equipment, Disinfectors, Sterilization Equipment, Services, Consumables), By End-use (Hospitals, Clinical Laboratories, Pharmaceutical Companies), And Segment Forecasts, 2014 - 2025

  • LinkedIn
  • facebook
  • Twitter
出版日期:2017/05/09
頁  數:100頁
文件格式:PDF
價  格:
USD 4,950 (Single-User License)
USD 7,950 (Multi-User License)
USD 9,950 (Global-User License)
線上訂購或諮詢
The global infection control market is expected to reach USD 258.3 billion by 2025, according to a new report by Grand View Research, Inc. The market is driven by rising concerns with respect to a significant upsurge in hospital acquired infections globally. This is believed to facilitate greater penetration of infection control products. An influx in development of new biologics and subsequent demand for sterilized formulations serve as key growth factors for the overall infection control market. The healthcare organizations are focused on implementing strategies for early recognition, reporting, isolation, and surveillance of disease episodes of potential public health concern. In addition, increasing number intensive training modules, for nurses and other medical staff, on infection prevention and control is presumed to provide high potential for extensive usage of infection control products over the coming years.
For instance, College of Nurses of Ontario released guidelines concerning standard practices, that is focused on maintaining hand hygiene to reduce contamination and spread of infection. Furthermore, Centers for Disease Control and Prevention (CDC) has released guidelines for disinfection and sterilization for efficient usage of infection control products by healthcare personnel in wide array of healthcare settings such as ambulatory care, home care, hospitals, and others. As a consequence of the aforementioned factors, it is presumed that there will be significant improvement in the overall penetration rate of infection prevention and control products, which is also anticipated to fuel the market demand as well as the revenue to unprecedented heights.
Further key findings from the report suggest:
‧ In the type segment, services are predicted to observe exponential growth as a consequence of increasing presence of third-party reprocessors and outsourcing of sterilization as a result of associated cost efficiency
‧ In the end-use segment, hospitals accounted for substantial share in 2016, as a consequence of high clinical urgency to curb the growing incidence of hospital acquired infections
‧ North America captured a dominant share of the overall infection control market owing to extensive infection prevention activities being implemented in hospitals, medical device and pharmaceutical companies
‧ The market in Asia Pacific is projected to witness exponential growth during the forecast period as a result of increasing awareness pertaining to spread of infections within healthcare settings and measures for prevention
‧ The competitive environment is marked by companies adopting sustainability strategies such as geographical expansion and mergers & acquisitions resulting in significant growth in their market share
‧ For instance, in July 2016, the Getinge Group acquired 1stCall Mobility Ltd, a company specializing in supplying rental equipment. This acquisition was carried out as a part of the company’s expansion strategy
Table of Contents
Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region-wise market: Base estimates
1.1.2 Global market: CAGR calculation
1.2 Region-Based Segment Share Calculation
1.3 List of Secondary Sources
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.3 Market Restraint Analysis
3.4 Penetration & Growth Prospect Mapping
3.5 Infection Control Market - SWOT Analysis, by Factor (Political & legal, economic and technological)
3.6 Industry Analysis - Porter’s Five Forces Model
Chapter 4 Infection Control Market: Type Estimates & Trend Analysis
4.1 Infection Control Market: Type Movement Analysis
4.2 Equipment
4.2.1 Equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.2 Disinfectors
4.2.2.1 Disinfectors market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.2.2 Washers
4.2.2.2.1 Washers market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.2.3 Flushers
4.2.2.3.1 Flushers market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.2.4 Endoscope reprocessors
4.2.2.4.1 Endoscope reprocessors market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.3 Sterilization equipment
4.2.3.1 Sterilization equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.3.2 Heat sterilization equipment
4.2.3.2.1 Heat sterilization equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.3.3 Low temperature equipment
4.2.3.3.1 Low temperature equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.3.4 Radiation sterilization equipment
4.2.3.4.1 Radiation sterilization equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.3.5 Filtration sterilization equipment
4.2.3.5.1 Filtration sterilization equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.2.3.6 Liquid sterilization equipment
4.2.3.6.1 Liquid sterilization equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3 Services
4.3.1 Services market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3.2 Contract sterilization
4.3.2.1 Contract sterilization market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3.2.2 Ethylene oxide sterilization
4.3.2.2.1 Ethylene oxide sterilization market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3.2.3 E-beam sterilization
4.3.2.3.1 E-beam sterilization market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3.2.4 Gamma sterilization
4.3.2.4.1 Gamma sterilization market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3.2.5 Others
4.3.2.5.1 Others market estimates and forecasts, 2014 - 2025 (USD Billion)
4.3.3 Waste disposal
4.3.3.1 Waste disposal market estimates and forecasts, 2014 - 2025 (USD Billion)
4.4 Consumables
4.4.1 Consumables market estimates and forecasts, 2014 - 2025 (USD Billion)
4.4.2 Waste disposal
4.4.2.1 Waste disposal market estimates and forecasts, 2014 - 2025 (USD Billion)
4.4.3 Disinfectants
4.4.3.1 Disinfectants market estimates and forecasts, 2014 - 2025 (USD Billion)
4.4.4 Sterilization supplies
4.4.4.1 Sterilization supplies market estimates and forecasts, 2014 - 2025 (USD Billion)
4.4.5 Personal protective equipment
4.4.5.1 Personal protective equipment market estimates and forecasts, 2014 - 2025 (USD Billion)
4.4.6 Others
4.4.6.1 Others market estimates and forecasts, 2014 - 2025 (USD Billion)
Chapter 5 Infection Control Market: End-use Estimates & Trend Analysis
5.1 Infection Control Market: End-use Movement Analysis
5.2 Hospitals
5.2.1 Hospitals market estimates and forecasts, 2014 - 2025 (USD Billion)
5.3 Medical Device Companies
5.3.1 Medical device companies market estimates and forecasts, 2014 - 2025 (USD Billion)
5.4 Clinical Laboratories
5.4.1 Clinical laboratories market estimates and forecasts, 2014 - 2025 (USD Billion)
5.5 Pharmaceutical Companies
5.5.1 Pharmaceutical companies market estimates and forecasts, 2014 - 2025 (USD Billion)
5.6 Others
5.6.1 Others market estimates and forecasts, 2014 - 2025 (USD Billion)
Chapter 6 Infection Control Market: Regional Estimates & Trend Analysis, by Type & End-Use
6.1 Infection Control Market Shares by Region, 2016 & 2025
6.2 North America
6.2.1 North America infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.2.2 North America infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.2.3 U.S.
6.2.3.1 U.S. infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.2.3.2 U.S. infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.2.4 Canada
6.2.4.1 Canada infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.2.4.2 Canada infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.3 Europe
6.3.1 Europe infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.3.2 Europe infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.3.3 Germany
6.3.3.1 Germany infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.3.3.2 Germany infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.3.4 UK
6.3.4.1 UK infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.3.4.2 UK infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.4.2 Asia Pacific infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.4.3 Japan
6.4.3.1 Japan infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.4.3.2 Japan infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.4.4 China
6.4.4.1 China infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.4.4.2 China infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.4.5 India
6.4.5.1 India infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.4.5.2 India infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.5 Latin America
6.5.1 Latin America infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.5.2 Latin America infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.5.3 Brazil
6.5.3.1 Brazil infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.5.3.2 Brazil infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.5.4 Mexico
6.5.4.1 Mexico infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.5.4.2 Mexico infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.6 MEA
6.6.1 MEA infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.6.2 MEA infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
6.6.2.1 MEA infection control market estimates and forecasts, 2014 - 2025 (USD Billion)
6.6.3 South Africa
6.6.3.1 South Africa infection control market estimates and forecasts, by type, 2014 - 2025 (USD Billion)
6.6.3.2 South Africa infection control market estimates and forecasts, by end-use, 2014 - 2025 (USD Billion)
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Market participation categorization
7.3 Company Profiles
7.3.1 3M Company
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Belimed AG
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 Halyard Health, Inc.
7.3.3.1 Company overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Getinge Group
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic initiatives
7.3.5 Advanced Sterilization Products
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Matchana Group
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.7 Sterigenics International
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic initiatives
7.3.8 MMM Group
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.8.4 Strategic initiatives
7.3.9 Cantel Medical Corporation
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic initiatives
7.3.10 STERUS Corporation
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic initiatives
回上頁